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ABSTRACT
Here we report a single pedigree affected by two different recessive neuromuscular disorders, namely Fried-
reich ataxia (FRDA) and Limb-Girdle Muscular Dystrophy Type 2А (LGMD2A). The molecular genetic test-
ing showed that in this family FRDA is caused by an expanded GAA repeat in compound heterozygous state 
with a novel point mutation c.442C>T, p.Gln148* on the other allele of the FXN gene. This case of two sib-
lings (16 years old male and 18 years old female) is the first report of Bulgarian FRDA case carrying a point 
mutation in the FXN gene. The LGMD2A affected individual (second cousin of the FRDA affected patients) 
was found to be compound heterozygous for the two most common CAPN3 mutations for the Bulgarian 
population (c.550delA, p.Thr184Argfs; c.967G>T, p.Glu323*). To the best of our knowledge we are reporting 
the first Bulgarian family with two neurological disorders caused by mutations in genes on different chro-
mosomes and segregating independently in the family. This single pedigree with four different mutations 
in two different genes (in both disorders due to compound heterozygosity) is an example for the high genet-
ic heterogeneity of the Bulgarian population.
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INTRODUCTION
Friedreich ataxia (FRDA, MIM 229300) is an 
autosomal recessive form of ataxia characterized 
mainly by dysarthria, muscle weakness and spastic-
ity in the lower limbs. It is a progressive disorder of 
the nervous system with usual onset before the end of 
puberty (1). FRDA is caused by mutations in the FXN 
gene (MIM 606829) which is localized at 9q21.11. 
Typically, the disorder is associated with an unsta-
ble GAA trinucleotide expansion in intron 1. Ho-
mozygous expansion accounts for 98% of the cases 
of FRDA. However, about 2% of the FRDA patients 
are compound heterozygous for the expansion and a 
point mutation in the FXN gene (2).
Limb-Girdle Muscular Dystrophy Type 2A 
(LGMD2A, MIM 253600; Calpainopathy) is anoth-
er autosomal recessive neuromuscular disorder pre-
sented with progressive proximal (limb-girdle) mus-
cle weakness. The onset and phenotype show signif-
icant variability between the different families and 
the different individuals in the same family. Calpain-
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recessive neuromuscular disorder - LGMD2A. Fig-
ure 1 illustrates the pedigree of the family we have 
examined. The FRDA affected individuals (IV-1 and 
IV-2) and the LGMD2A affected patient (IV-5) are 
second cousins. The IV-5 patient is a 15 years old fe-
male at the time when the genetic analysis was per-
formed with typical clinical presentation of LGM-
D2A: proximal weakness, weakness in the upper 
limb and the shoulder girdle, severe contractures and 
spine deformities.
Our study started from a healthy relative of the 
presented patients (female, 31 years old; IV-3), in the 
context of genetic counseling. She is a first cousin 
of the FRDA affected (IV-1, IV-2) and second cous-
in of the LGMD2A affected (IV-5) family members. 
The individuals affected by FRDA (IV-1, IV-2) and 
by LGMD2A (IV-5) are part of an extended pedi-
gree, but originate from two different nuclear fami-
lies without any consanguinity.
opathy is caused by mutations in the CAPN3 gene 
(MIM 114240) localized at 15q15.1 (3).
CASE PRESENTATION 
Here we present a family with two FRDA affect-
ed children – а male, 16 years old at the moment of 
the genetic testing and still ambulant but with severe 
difficulties in walking, and female, 18 years old and 
already wheel-chair bounded. Both children pres-
ent with typical clinical manifestations with an on-
set before puberty. The first symptoms included poor 
walking balance and slurred speech. With the pro-
gression of the disease the patients experienced dys-
arthria and muscle weakness in hip extensors and 
abductors, followed by distal limb muscle weakness 
and wasting. Spasticity in the lower limbs became 
prominent.
It is interesting to note that in the same family 
there is also another genetically verified autosomal 
Fig. 1. Family pedigree; squares indicate males; circles – females; open symbols represent normal subjects; striped sym-
bols – FRDA affected individuals; semistriped symbols – FRDA carriers; dotted symbols – LGMD2A affected individu-
als; semidotted symbols – LGMD2A carriers; the individuals with unknown genotype are marked by a question mark. 
The consulting individual is marked by an arrow
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METHODS
Mutation analysis of the FXN and CAPN3 gene 
was performed. Primers were designed to specifi-
cally amplify all exons and intron/exon boundar-
ies. Direct sequencing of the amplified products was 
performed using BigDye Terminator v3.1 Cycle Se-
quencing Kit (Applied Biosystems, Foster city, CA) in 
order to detect point mutations. The GAA repeat ex-
pansion was detected by short PCR for identification 
of normal and TP-PCR for identification of expand-
ed alleles. Normal alleles in healthy controls contain 
5-60 GAA repeats. In Friedreich’s Ataxia patients, 
the GAA repeat varies from 66 to 1700.
RESULTS AND DISCUSSION
Both FRDA affected patients (IV-1, IV-2) are 
carrying a GAA expansion in compound hetero-
zygous state with a nonsense mutation c.442C>T, 
p.Gln148*. The female (IV-2) has been tested by 
Southern blot (through foreign collaboration) reveal-
ing a size of the expansion of about 700±1 GAA re-
peats. Molecular genetic testing of the male sibling 
was executed only by TP-PCR to confirm the ex-
panded allele (>66 GAA repeats), although not giv-
ing the possibility to determine the exact size of the 
expansion. Only 2% of the FRDA patients are com-
pound heterozygous for the expansion and a point 
mutation in this gene (2). To the best of our knowl-
edge this is the first FRDA case in Bulgaria with a 
point mutation in the FXN gene. Moreover, the de-
tected nonsense change c.442C>T, p.Gln148* has not 
been previously reported. 
The molecular genetic testing of the LGMD2A 
patient (IV-5) showed that she was compound het-
erozygous for two severe inactivating mutations in 
the CAPN3 gene: c.550delA, p.Thr184Argfs in exon 
4 transmitted by the mother (III-7) and c.967G>T, 
p.Glu323* in exon 7 inherited from the father (III-6). 
These two mutations are the most common for the 
Bulgarian population (4). 
The consulting individual has been tested for 
the family mutations in both FXN and CAPN3 gene. 
The molecular genetic testing showed that she is an 
asymptomatic carrier of the GAA expansion in the 
FXN gene (detected trough TP-PCR). Fortunately 
none of the familial mutations in the CAPN3 gene 
were inherited by her. From the genotype of the in-
dex patient and this of patients IV-1, IV-2 (carrying 
the GAA expansion) we can conclude that both the 
mother of the consulting female and the father of the 
FRDA patients (they are siblings) are carriers of the 
GAA expansion (although not tested as they are not 
willing to be part of the present study). The affected 
LGMD2A patient IV-5 turned out to be negative for 
the GAA expansion. Therefore, we cannot conclude 
if II-1 and II-3 have carried the GAA expansion in 
the FXN gene together with the familial p.Glu323* 
mutation in the CAPN3 gene and whether these two 
genetic defects originate from a single parental pair 
(I-1 and I-2). Unfortunately, it is not possible to follow 
further these two pathologies within the pedigree.
Worldwide there are very few reported cases 
with more than one rare genetic disorder in the same 
pedigree. In the Bulgarian population there has been 
found a family with three genetic disorders Fragile X 
syndrome (FraX, MIM 300624), Duchene muscular 
dystrophy (DMD, MIM 310200) and X-linked ich-
thyosis (XLI, MIM 308100), but all of them caused by 
defects affecting loci on the X chromosome (5). Pre-
viously there has been described one Bulgarian case 
of an extended pedigree with two rare genetic disod-
ers (6).
To the best of our knowledge we are report-
ing the first Bulgarian family with two neurological 
disorders caused by mutations in genes on different 
chromosomes and segregating independently in the 
family. Both neurological disorders presented in our 
family are rare with a prevalence of about 1:29 000 
(7) for FRDA and 1:100 000 for calpainopathy (8), 
with only 24 cases of calpainopathy in Bulgaria (9). 
Here, both pathologies are caused by compound het-
erozygous mutations and not by homozygous muta-
tions resulting from consanguineous marriages. The 
presence of four different protein truncating muta-
tions in a single family is an example of the high ge-
netic heterogeneity of the Bulgarian population. 
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